NCT01187485 2023-11-29
A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer
University of Chicago
Phase 1 Completed
University of Chicago
Memorial Sloan Kettering Cancer Center
Herlev Hospital
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center